Full story here (exclusive on Business Today): #Pharma #Healthcare #Diabetes #NovoNordisk #BusinessOfHealth To view or add a comment, sign in GLP1, Wegovy, has recently been FDA-approved for MASH patients with moderate-to-advanced fibrosis hot on the heels of last years approval of first-mover, Rezdifrra
Delivery method dramatically affects how much peptide actually gets where it needs to go
For instance, direct-to-consumer advertising must balance persuasive messaging with clear risk disclosures
Which fruit has the most glutathione
It is not dangerous
A review of pivotal clinical trials for semaglutide (STEP, SUSTAIN), dulaglutide (REWIND), liraglutide (LEADER), and tirzepatide (SURPASS, SURMOUNT) does not identify muscle cramps as occurring at significantly higher rates compared to placebo groups